A Pilot Study in Severe Patients With Takayasu Arteritis.

Clinical trial NCT04300686 · RECRUITING

Trial details

NCT number: NCT04300686
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Takayasu Arteritis Tocilizumab Adalimumab Treatment

Start date: 2020-03-01
Primary completion: 2022-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.